Table 5.
r/ma | ρ/θb | Reference | |
---|---|---|---|
L. innocua | 3.144 (2.234-4.071) | 0.535 (0.396-0.764) | This study |
L. innocua subgroup A | 12.036 (5.404-20.716) | 3.770 (2.021-6.188) | This study |
L. innocua subgroup B | 4.813 (1.431-20.455) | 0.282 (0.095-1.124) | This study |
L. monocytogenes | 1.847 (1.293-2.641) | 0.179 (0.135-0.258) | This study |
L. monocytogenes lineage I | 5.752 (1.413-18.660) | 0.055 (0.023-0.118) | This study |
L. monocytogenes lineage II | 7.610 (5.096-11.065) | 0.518 (0.244-0.801) | This study |
L. monocytogenes lineage III | 1.869 (0.720-5.117) | 0.195 (0.066-0.661) | This study |
L. innocua-L. monocytogenes clade | 2.783 (2.326-3.307) | 0.334 (0.284-0.395) | This study |
Bacillus anthracis-Bacillus cereus clade | ND | 0.2-0.5 | Didelot et al. 2007 |
Clostridium perfringens | ND | 3.2 | Rooney et al. 2006 |
Neisseria meningitis | ND | 1.1 | Jolley et al. 2005 |
Staphylococcus aureus | ND | 0.11 | Fraser et al. 2005 |
Streptococcus pneumoniae | ND | 2.1 | Fraser et al. 2005 |
ND, not done.
a. The ratio of probabilities that a given site is altered through recombination and mutation, representing a measure of how important the effect of recombination is in the diversification of the sample relative to mutation.
b. The ratio of rates at which recombination and mutation occur, representing a measure of how often recombination events happen relative to mutations.